INSIGHTS ON LIQUID DOSE MANUFACTURING

• Quadrupling Inspection Speed With Automated Visual Inspection (AVI)

  JHS boosted vaccine vial inspection speed 4x with automated visual inspection, improving accuracy, efficiency, and capacity to 20 million vials annually using the Seidenader CS-40.

• Explore A High-Performing Basal Medium And Feed Pairing

  A customer sought to replace a chemically defined CHO medium with a more efficient medium and feed pairing strategy in bioreactors.

• Importance Of Assessing Mannitol Crystallinity In Lyophilized Drug Products

  Drug product stability may be seriously compromised if mannitol completes crystallization during storage rather than during the freezing or annealing step in the lyophilization process.

• Formulation Development For Therapeutic Oligonucleotides

  Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.

• Understanding Injectable Drug Container Closure Systems

  6/20/2024

  Choosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential.

• De-Risking A Novel Valve Component For Use With Standard Syringe Systems

  3/16/2026

  A novel valve provides dual‑chamber functionality within standard syringes, keeping two liquid drugs separated until injection while reducing development risk through advanced modeling.

• Vaccine Fill Line Operations

  11/24/2025

  Learn how adopting a harmonized, risk-based validation strategy across global sites can reduce operational readiness timelines and drive improvements in equipment effectiveness and regulatory compliance

• Enhancing Automated Environmental Monitoring In Gloveless Isolators

  1/7/2026

  Explore how automation and robotic-friendly solutions are transforming fill-and-finish operations and gain insights into gloveless processes, EM testing challenges, and collaborative innovations.

• How Asia and Europe Are Reshaping Biologics Manufacturing

  4/9/2026

  As biologics manufacturing globalizes, companies must balance cost, capacity, risk, and control when choosing between European and Asian supply bases for clinical and commercial success.